TNF and inflammatory bowel disease: Here, we hypothesized that a multicohort analysis of transcriptomic data from baseline (pretreatment) intestinal mucosal biopsies from patients with IBD across heterogeneous datasets would identify a robust generalizable gene expression signature predictive of a patient’s response to anti-TNFα therapy.